Valeria Santini, MD

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Keros
    Date added:
    06/10/2026
    Date updated:
    06/10/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Novartis
    Date added:
    06/10/2026
    Date updated:
    06/10/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Menarini
    Date added:
    06/10/2026
    Date updated:
    06/10/2026
    Relationship end date:
    09/01/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Servier
    Date added:
    06/10/2026
    Date updated:
    06/10/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    CTI
    Date added:
    06/10/2026
    Date updated:
    06/10/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Syros
    Date added:
    06/10/2026
    Date updated:
    06/10/2026
  • Attribution:
    Self
    Type of financial relationship:
    Speaker
    Ineligible company:
    AbbVie
    Date added:
    06/10/2026
    Date updated:
    06/10/2026
  • Attribution:
    Self
    Type of financial relationship:
    Speaker
    Ineligible company:
    Ascentage
    Date added:
    06/10/2026
    Date updated:
    06/10/2026
  • Attribution:
    Self
    Type of financial relationship:
    Speaker
    Ineligible company:
    Bristol Myers Squibb/Celgene
    Date added:
    06/10/2026
    Date updated:
    06/10/2026
  • Attribution:
    Self
    Type of financial relationship:
    Speaker
    Ineligible company:
    Curis
    Date added:
    06/10/2026
    Date updated:
    06/10/2026
    Relationship end date:
    09/01/2025

Pages

Return to Momentum in MDS: Making Progress and Shaping a Better Future